Steven A Maxwell

Title: Innovations by Steven A Maxwell

Introduction

Steven A Maxwell is a notable inventor based in College Station, TX (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 3 patents, Maxwell's work focuses on enhancing the effectiveness of cancer therapies.

Latest Patents

One of Maxwell's latest patents is centered around "Compositions and methods for drug-sensitization or inhibition of a cancer cell." This patent discloses rifamycin and rifamycin derivative compositions, including rifabutin and rifabutin derivative compositions. These compositions are designed to cause drug-sensitization in cancer cells or directly inhibit their growth. The patent also outlines methods for administering these compositions to cancer cells, aiming to sensitize them to chemotherapeutics or inhibit them directly. Furthermore, it provides methods for increasing reactive oxygen species (ROS), particularly superoxides, in cancer cells. Additionally, the patent includes methods for determining whether a cancer will respond to chemotherapeutics based on ROS levels in the cancer cells of a patient.

Career Highlights

Steven A Maxwell is affiliated with the Texas A&M University System, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to improve patient outcomes in cancer therapy.

Collaborations

Maxwell collaborates with esteemed colleagues such as James C Sacchettini and Niam Zhou, contributing to a dynamic research environment focused on innovative cancer treatments.

Conclusion

Steven A Maxwell's contributions to cancer research through his patented inventions highlight his commitment to improving therapeutic strategies. His work exemplifies the intersection of innovation and healthcare, aiming to make a significant impact in the fight against cancer.